Solid Microneedles for Transdermal Delivery of Amantadine Hydrochloride and Pramipexole Dihydrochloride

被引:66
作者
Hoang, Mylien T. [1 ]
Ita, Kevin B. [1 ]
Bair, Daniel A. [2 ]
机构
[1] Touro Univ, Coll Pharm, Mare Isl Vallejo, CA 94592 USA
[2] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA
来源
PHARMACEUTICS | 2015年 / 7卷 / 04期
关键词
transdermal; solid microneedles; microneedle roller; percutaneous flux; burst force;
D O I
10.3390/pharmaceutics7040379
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this project was to study the influence of microneedles on transdermal delivery of amantadine hydrochloride and pramipexole dihydrochloride across porcine ear skin in vitro. Microchannel visualization studies were carried out and characterization of the microchannel depth was performed using confocal laser scanning microscopy (CLSM) to demonstrate microchannel formation following microneedle roller application. We also report, for the first time, the use of TA. XT Plus Texture Analyzer to characterize burst force in pig skin for transdermal drug delivery experiments. This is the force required to rupture pig skin. The mean passive flux of amantadine hydrochloride, determined using a developed LC-MS/MS technique, was 22.38 +/- 4.73 mu g/cm(2)/h, while the mean flux following the use of a stainless steel microneedle roller was 49.04 +/- 19.77 mu g/cm(2)/h. The mean passive flux of pramipexole dihydrochloride was 134.83 +/- 13.66 mu g/cm(2)/h, while the flux following the use of a stainless steel microneedle roller was 134.04 +/- 0.98 mu g/cm(2)/h. For both drugs, the difference in flux values following the use of solid stainless steel microneedle roller was not statistically significantly (p > 0.05). Statistical analysis was carried out using the Mann-Whitney Rank sum test.
引用
收藏
页码:379 / 396
页数:18
相关论文
共 60 条
  • [1] Parkinson's disease and age: The obvious but largely unexplored link
    Abdullah, Rashed
    Basak, Indranil
    Patil, Ketan S.
    Alves, Guido
    Larsen, Jan Petter
    Moller, Simon Geir
    [J]. EXPERIMENTAL GERONTOLOGY, 2015, 68 : 33 - 38
  • [2] Randomized, placebo-controlled study of tolcapone in patients with fluctuating Parkinson disease treated with levodopa-carbidopa
    Adler, CH
    Singer, C
    O'Brien, C
    Hauser, RA
    Lew, MF
    Marek, KL
    Dorflinger, E
    Pedder, S
    Deptula, D
    Yoo, K
    [J]. ARCHIVES OF NEUROLOGY, 1998, 55 (08) : 1089 - 1095
  • [3] Ahad M.A. A., 2010, ASIAN J PHARM SCI, V5, P276
  • [4] Skin penetration enhancement by a microneedle device (Dermaroller®) in vitro: Dependency on needle size and applied formulation
    Badran, M. M.
    Kuntsche, J.
    Fahr, A.
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 36 (4-5) : 511 - 523
  • [5] Transdermal Drug Delivery In Vitro Using Diffusion Cells
    Bartosova, L.
    Bajgar, J.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2012, 19 (27) : 4671 - 4677
  • [6] Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism
    Chase, TN
    Oh, JD
    [J]. TRENDS IN NEUROSCIENCES, 2000, 23 (10) : S86 - S91
  • [7] Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
    Chaudhuri, K. Ray
    Schapira, Anthony H. V.
    [J]. LANCET NEUROLOGY, 2009, 8 (05) : 464 - 474
  • [8] Pharmacological Treatment of Parkinson Disease A Review
    Connolly, Barbara S.
    Lang, Anthony E.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (16): : 1670 - 1683
  • [9] Biomechanics of Scar Tissue and Uninjured Skin
    Corr, David T.
    Hart, David A.
    [J]. ADVANCES IN WOUND CARE, 2013, 2 (02) : 37 - 43
  • [10] MODIFICATION OF PARKINSONISM - CHRONIC TREATMENT WITH L-DOPA
    COTZIAS, GC
    PAPAVASI.PS
    GELLENE, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (07) : 337 - &